natgillin/translations-raw huggingface dataset:
Daivobet should not be used in patients who may be hypersensitive (allergic) to the active substances or to any other ingredient. 
Zdravila Daivobet ne smejo uporabljati bolniki, ki utegnejo biti preobčutljivi za (alergični na) zdravilni učinkovini ali katero koli drugo sestavino zdravila.
For the gel, the recommended treatment period is four weeks for scalp psoriasis and eight weeks for non-scalp psoriasis. 
Priporočeno obdobje zdravljenja z gelom je štiri tedne pri psoriazi lasišča in osem tednov pri psoriazi, ki se ne pojavlja na lasišču.
Daivobet is used to treat adults with psoriasis (a disease causing red, scaly patches on the skin). 
Zdravilo Daivobet se uporablja za zdravljenje odraslih bolnikov s psoriazo (boleznijo, ki povzroča rdeče, luskaste površine na koži).
Daivobet must not be used in patients who have some types of psoriasis that is red and flaking off or filled with pus. 
Zdravila Daivobet ne smejo uporabljati bolniki z nekaterimi vrstami psoriaze, ki je rdeča in luskava ali ognojena.
Daivobet gel is for the treatment of psoriasis on the scalp or mild to moderate plaque psoriasis on other parts of the body. 
Daivobet gel je namenjen zdravljenju psoriaze na lasišču ali blage do zmerne psoriaze s plaki na drugih delih telesa.
For the full list, see the harmonised SmPC. 
Za celoten seznam glejte usklajen povzetek glavnih značilnosti zdravila.
On 10 March 2010, Leo Pharmaceutical Products referred Daivobet to the CHMP in order to harmonise the marketing authorisations for the product in the EU. 
Da bi uskladila dovoljenja za promet z zdravilom Daivobet v EU, je družba Leo Pharmaceutical Products dne 10. marca 2010 zadevo napotila na CHMP.
Betamethasone is an anti-inflammatory medicine that helps to reduce the inflammation and itching that occur with psoriasis. 
Betametazon je protivnetno zdravilo, ki pomaga zmanjševati vnetje in srbenje, ki se pojavljata pri psoriazi.
Company responses provided on: 16 June 2010 Opinion date: 
Odgovori družbe, poslani dne:
Do not take two doses in one day. 
Ne vzemite dveh odmerkov v enem dnevu.
Drink it straight away. 
Napitek takoj spijte.
(See sections 4.5 and 5.2). 
(Glejte poglavji 4.5 in 5.2.)
Information on long term safety is primarily limited to open-label, uncontrolled data. 
Informacije o dolgoročni varnosti so primarno omejene na nenadzorovane podatke odprtih študij.
Common: Dry mouth 
Pogosti: suha usta
This will usually pass on its own but if it does not, tell your doctor. 
To običajno mine samo od sebe, če pa ne, povejte zdravniku.
You and your doctor should check your weight regularly. 
Vi in vaš zdravnik morata redno spremljati vašo telesno maso.
With some drinks, the mixture may change colour and possibly become cloudy. 
V nekaterih napitkih lahko mešanica spremeni barvo in postane motna.
This leaflet was last revised in {month XXXX}. 
Navodilo je bilo nazadnje revidirano v {mesec LLLL}
People with this disease may also feel depressed, anxious or tense. 
Ljudje s to boleznijo se lahko počutijo tudi depresivno, občutijo tesnobo ali napetost.
Your doctor may suggest you to reduce the dose gradually before stopping treatment. 
Vaš zdravnik vam bo morda predlagal postopno nižanje odmerka pred ukinitvijo zdravljenja.
Increased total bilirubin 
zvišan celokupni bilirubin
• If you have been previously diagnosed with eye problems such as certain kinds of glaucoma (increased pressure in the eye). 
• če so vam v preteklosti ugotovili težave z očmi kot je določena vrsta glavkoma (povišan tlak v očesu).
No studies on the effects on the ability to drive and use machines have been performed. 
Študije o vplivu na sposobnost vožnje in upravljanja s stroji niso izvedli.
If this has happened to you, tell your doctor. 
Če se vam je zgodilo kaj takega, povejte zdravniku.
• Medicines of this type may cause unusual movements mainly of the face or tongue. 
• Tovrstna zdravila lahko povzročijo nenavadne zgibke predvsem v mišicah obraza ali jezika.
Discontinuation symptoms7, 12 
odtegnitveni simptomi7, 12
Glucosuria Increased appetite 
glikozurija povečan apetit
In the early stages of treatment, some people may feel dizzy or faint (with a slow heart rate), especially when getting up from a lying or sitting position. 
Nekateri ljudje imajo lahko v začetnih obdobjih zdravljenja občutek omotice ali oslabelosti (z upočasnjenim srčnim utripom), zlasti pri vstajanju iz ležečega ali sedečega položaja.
Your doctor will tell you how many Olanzapine Apotex tablets to take and how long you should continue to take them. 
Zdravnik vam bo povedal, koliko Olanzapin Apotex tablet morate vzeti in kako dolgo naj bi jih jemali.
Olanzapine is not recommended for use in children and adolescents below 18 years of age due to a lack of data on safety and efficacy. 
Uporaba olanzapina ni priporočena pri otrocih in mladostnikih, mlajših od 18 let, zaradi pomanjkanja podatkov o varnosti in učinkovitosti.
• If you are allergic (hypersensitive) to olanzapine or any of the other ingredients of this medicine (listed in section 6). 
• če ste alergični na (preobčutljivi za) olanzapin ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
Removal of the intact orodispersible tablet from the mouth is difficult. 
Odstranitev cele orodisperzibilne tablete iz ust je težavna.
In adult patients who completed 9-12 months of therapy, the rate of increase in mean blood glucose slowed after approximately 6 months. 
Pri odraslih bolnikih, ki so zaključili 9-12 mesecev terapije, se je razmerje zvišanja povprečne glukoze v krvi upočasnilo po približno 4-6 mesecih.
The following table lists the adverse reactions and laboratory investigations observed from spontaneous reporting and in clinical trials. 
Naslednja tabela našteva neželene učinke in laboratorijske preiskave, ki so jih opazili iz spontanega poročanja in kliničnih preskušanj.
Your doctor should do blood tests to check blood sugar and certain fat levels before you start taking Olanzapine Apotex and regularly during treatment. 
Vaš zdravnik mora opraviti krvni test za preiskavo sladkorja v krvi in nivo določenih maščob pred začetkom jemanja zdravila Olanzapin Apotex in redno tekom zdravljenja.
The frequency terms listed are defined as follows: Very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000), not known (cannot be estimated from the available data). 
Našteti izrazi pogostnosti so definirani kot sledi: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do 1/1.000), zelo redki (< 1/10.000), neznana (ni mogoče oceniti iz razpoložljivih podatkov).
Dose escalation, when indicated, should be conservative in such patients. 
Višanje odmerka, kadar je to indicirano, naj bo pri takih bolnikih previdno.
Children and adolescents Olanzapine Apotex is not for patients who are under 18 years. 
Otroci in mladostniki Zdravilo Olanzapin Apotex ni namenjeno bolnikom, mlajšim od 18 let.
You can also place the tablet in a full glass or cup of water, orange juice, apple juice, milk or or coffee and stir. 
Tableto lahko date tudi v poln kozarec ali skodelico vode, oranžnega soka, jabolčnega soka, mleka ali kave in premešate.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product. 
Če vam je zdravnik povedal, da imate intoleranco za nekatere sladkorje, se pred jemanjem tega zdravila posvetujte z zdravnikom.
Because olanzapine may cause somnolence and dizziness, patients should be cautioned about operating machinery, including motor vehicles. 
Ker olanzapin lahko povzroči zaspanost in omotičnost, je treba bolnike opozoriti na previdnost glede upravljanja s stroji, vključno z motornimi vozili.
Clinically significant weight gain (≥ 7%) appears to occur more frequently in the adolescent population compared to adults with comparable exposures. 
Videti je, da se klinično značilno zvečanje telesne mase (≥ 7 %) pojavlja pogosteje pri populaciji mladostnikov v primerjavi z odraslimi pri primerljivi izpostavljenosti.
During treatment with olanzapine, adolescents gained significantly more weight compared with adults. 
Med zdravljenjem z olanzapinom so mladostniki pridobili signifikantno več telesne mase v primerjavi z odraslimi.
Very rare side effects include serious allergic reactions such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). 
Zelo redki neželeni učinki vključujejo resne alergijske reakcije, kot je reakcija na zdravilo z eozinofilijo in sistemskimi simptomi (DRESS).
In clinical studies, the average olanzapine exposure was approximately 27% higher in adolescents. 
V kliničnih študijah je bila povpreča izpostavitev približno 27 % višja pri mladostnikih.
Tell your doctor immediately if you have: 
Takoj obvestite zdravnika, če opazite:
However, olanzapine (5-20 mg) demonstrated a comparable safety profile in female (n = 467) as in male patients (n = 869). 
Vendar pa je olanzapin (5-20 mg) pokazal primerljiv profil varnosti tako pri bolnikih ženskega (n = 467) kot moškega spola (n = 869).
Based on the results of studies in mice and rats, it was concluded that olanzapine is not carcinogenic. 
Na podlagi izsledkov študij peroralnega olanzapina na miših in podganah je bilo zaključeno, da olanzapin ni kancerogen.
Activated charcoal reduces the bioavailability of oral olanzapine by 50 to 60% and should be taken at least 2 hours before or after olanzapine. 
Aktivno oglje zmanjša biološko uporabnost peroralnega olanzapina za 50 do 60 % in ga je treba zaužiti vsaj 2 uri pred olanzapinom ali vsaj dve uri po njem.
• The use of Olanzapine Apotex in elderly patients with dementia is not recommended as it may have serious side effects. 
• Uporaba zdravila Olanzapin Apotex ni priporočljiva pri starejših bolnikih z demenco, saj lahko povzroči resne neželene učinke.
Dementia-related psychosis and/or behavioural disturbances Olanzapine is not recommended for use in patients with dementia-related psychosis and/or behavioural disturbances because of an increase in mortality and the risk of cerebrovascular accident. 
Psihoza, povezana z demenco in/ali vedenjske motnje Olanzapin ni priporočljiv za uporabo pri bolnikih s psihozo, povezano z demenco in/ali vedenjskimi motnjami zaradi povečane umrljivosti in tveganja za cerebrovaskularne dogodke.
The mean increase in olanzapine Cmax following fluvoxamine was 54 % in female non-smokers and 77 % in male smokers. 
Srednje zvišanje Cmax olanzapina po dajanju fluvoksamina je bilo 54 % pri ženskah nekadilkah in 77 % pri moških kadilcih.
Age > 75 years and vascular/mixed type dementia were identified as risk factors for CVAE in association with olanzapine treatment. 
Starost > 75 let in vaskularna/mešana demenca sta bili določeni kot dejavnika, ki prispevata k tveganju za CVAE v povezavi z zdravljenjem z olanzapinom.
The frequency terms listed are defined as follows: Very common (≥ 1/10), common (≥ 1/100 to 
Našteti izrazi pogostnosti so definirani kot sledi: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10).
• medicines for Parkinson's disease. 
• zdravila za Parkinsonovo bolezen.
Olanzapine is an antipsychotic, antimanic and mood stabilising agent that demonstrates a broad pharmacologic profile across a number of receptor systems. 
Olanzapin je antipsihotik, antimanik in stabilizator razpoliženja, ki kaže širok farmakološki profil prek številnih receptorskih sistemov.
Mean infant exposure (mg/kg) at steady state was estimated to be 1.8% of the maternal olanzapine dose (mg/kg). 
Srednjo izpostavitev dojenčka (mg/kg) v stanju dinamičnega ravnovesja so ocenili na 1,8 % materinega odmerka olanzapina (mg/kg).
The following table summarises the adverse reactions reported with a greater frequency in adolescent patients (aged 13-17 years) than in adult patients or adverse reactions only identified during short-term clinical trials in adolescent patients. 
Naslednja tabela vključuje neželene učinke, ki so jih poročali z višjo pogostnostjo pri mladostnikih (starih 13-17 let) kot pri odraslih bolnikih ali neželene učinke, ki so jih ugotovili samo v kratkoročnih kliničnih preskušanjih pri mladostnikih.
Do not use epinephrine, dopamine, or other sympathomimetic agents with beta-agonist activity since beta stimulation may worsen hypotension. 
Ne uporabljajte adrenalina, dopamina ali drugih simpatikomimetikov z beta-agonističnim delovanjem, ker lahko beta stimulacija poslabša hipotenzijo.
• a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness (the frequency of this side effect cannot be estimated from the available data). 
• kombinacijo zvišane telesne temperature, pospešenega dihanja, znojenja, mišične okorelosti in dremavosti ali zaspanosti (pogostnosti tega neželenega učinka iz razpoložljivih podatkov ni mogoče oceniti).
If you notice any of these symptoms seek medical advice immediately; 
Če opazite katerega od teh simptomov, takoj poiščite zdravniško pomoč.
• carbamazepine (an anti-epileptic and mood stabiliser), fluvoxamine (an antidepressant) or ciprofloxacin (an antibiotic) - it may be necessary to change your Olanzapine Apotex dose. 
• karbamazepin (antiepileptik in stabilizator razpoloženja), fluvoksamin (antidepresiv) ali ciprofloksacin (antibiotik) - morda bo treba spremeniti vaš odmerek zdravila Olanzapin Apotex.
In patients with Parkinson's disease Olanzapine Apotex may worsen the symptoms. 
Pri bolnikih s Parkinsonovo boleznijo lahko zdravilo Olanzapin Apotex poslabša simptome.
Long-term olanzapine treatment (up to 12 months) for recurrence prevention in patients with bipolar disorder was associated with an increase of 7% from baseline body weight in 39.9% of patients. 
Dolgoročno zdravljenje z olanzapinom (do 12 mesecev) za preprečevanje ponovnega pojava bolezni pri bolnikih z bipolarno motnjo je bilo povezano s povečanjem telesne mase za ≥ 7 % z osnove pri 39,9 % bolnikov.
However, since patients with schizophrenia often present with acquired risk factors for venous thromboembolism all possible risk factors of VTE e.g. immobilisation of patients, should be identified and preventive measures undertaken. 
Vendar, ker imajo bolniki s shizofrenijo pogosto prisotne pridobljene dejavnike tveganja za vensko trombembolijo, je treba ugotoviti vse možne dejavnike tveganja za VTE, kot npr. imobilizacija bolnikov ter izvesti preventivne ukrepe.
A mass balance study showed that approximately 57% of radiolabelled olanzapine appeared in urine, principally as metabolites. 
Študija bilance snovi je pokazala, da se približno 57 % radioaktivno označenega olanzapina pojavi v urinu, predvsem v obliki metabolitov.
If you forget to take Olanzapine Apotex Take your tablets as soon as you remember. 
Če ste pozabili vzeti zdravilo Olanzapin Apotex Vzemite tablete, kakor hitro se spomnite.
In 44 patients with schizophrenia >65 years of age, dosing from 5 to 20 mg/day was not associated with any distinguishing profile of adverse events. 
Pri 44 bolnikih s shizofrenijo, starejših od > 65 let, odmerjanje od 5 do 20 mg/dan ni bilo povezano s kakim razločevalnim profilom neželenih učinkov.
You should not be given this medicine when breast-feeding, as small amounts of OlanzapineApotex can pass into breast milk 
Ko dojite, tega zdravila ne smete jemati, ker lahko majhne količine zdravila Olanzapin Apotex prehajajo v materino mleko.
Olanzapine Apotex belongs to a group of medicines called antipsychotics and is used to treat the following conditions: 
Zdravilo Olanzapin Apotex spada v skupino zdravil, imenovanih antipsihotiki in se uporablja za zdravljenje naslednjih bolezni:
In the same clinical trials, cerebrovascular adverse events (CVAE e.g., stroke, transient ischemic attack), including fatalities, were reported. 
V istih kliničnih preskušanjih so poročali o cerebrovaskularnih neželenih dogodkih (cerebrovascular adverse events - CVAE, npr. o možganski kapi, tranzitorni ishemični ataki), vključno s smrtnimi izidi.
The major circulating metabolite is the 10-N-glucuronide, which does not pass the blood brain barrier. 
V krvi je poglavitni metabolit 10-N-glukuronid, ki ne prehaja skozi krvno-možgansko pregrado.
Dystonia (including oculogyration) 11 
Distonija (vključno z okulogiracijo)11
Alternatively, it may be dispersed in a full glass of water or other suitable beverage (orange juice, apple juice, milk or coffee) immediately before administration. 
Druga možnost je, da se tik pred uporabo razpustijo v polnem kozarcu vode ali drugega primernega napitka (oranžni sok, jabolčni sok, mleko ali kava).
Since the orodispersible tablet is fragile, it should be taken immediately on opening the blister. 
Ker so orodisperzibilne tablete krhke, jih je treba uporabiti takoj, ko se jih vzame iz pretisnega omota.
What Olanzapine Apotex is and what it is used for What you need to know before you take Olanzapine Apotex How to take Olanzapine Apotex Possible side effects 
Kaj je zdravilo Olanzapin Apotex in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Olanzapin Apotex Kako jemati zdravilo Olanzapin Apotex Možni neželeni učinki
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines, thiazepines and oxepines, ATC code N05A H03. 
Farmakoterapevtska skupina: psiholeptiki, diazepini, oksazepini, tiazepini in oksepini, oznaka ATC: N05AH03.
An allergic reaction may be recognised as a rash, itching, a swollen face, swollen lips or shortness of breath. 
Alergijsko reakcijo lahko prepoznate kot izpuščaj, srbenje, otečen obraz, otečene ustnice ali težave pri dihanju.
Olanzapine is bound predominantly to albumin and 1-acid-glycoprotein. 
Olanzapin se veže predvsem na albumin in 1-kisli glikoprotein.
Elevated plasma prolactin levels were reported in 47.4% of adolescent patients. 
16 O zvišanih plazemskih koncentracijah prolaktina so poročali pri 47,4 % mladostnikov.
• Periodic Safety update Reports 
• Redno posodobljena poročila o varnosti zdravila (PSUR)
If this happens after you have been given Olanzapine Apotex tell your doctor. 
Če se vam to zgodi po tem, ko ste prejeli zdravilo Olanzapin Apotex, povejte zdravniku.
The concomitant use of olanzapine with anti-Parkinsonian medicinal products in patients with Parkinson's disease and dementia is not recommended (see section 4.4). 
Sočasna uporaba olanzapina z antiparkinsoniki pri bolnikih s Parkinsonovo boleznijo in demenco ni priporočena (glejte poglavje 4.4).
DRESS appears initially as flu-like symptoms with a rash on the face and then with an extended rash, high temperature, enlarged lymph nodes, increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell (eosinophilia). 
DRESS se na začetku kaže z gripi podobnimi simptomi z izpuščajem na obrazu in nato s podaljšanim izpuščajem, zvišano telesno temperaturo, povečanimi bezgavkami, zvišanimi ravnmi jetrnih encimov, kar pokažejo krvne preiskave, in povečanjem vrste belih krvnih celic (eozinofilija).
With long-term exposure (at least 24 weeks), 89.4 % gained ≥ 7 %, 55.3 % gained ≥ 15 % and 29.1 % gained ≥ 25% of their baseline body weight. 
Pri dolgoročni izpostavljenosti (najmanj 24 tednov) jih je 89,4 % pridobilo ≥ 7 %, 55,3 % ≥ 15 % in 29,1 % ≥ 25 % od njihove osnovne telesne mase.
It is important that you carry on taking Olanzapine Apotex for as long as your doctor tells you. 
Pomembno je, da nadaljujete z jemanjem zdravila Olanzapin Apotex tako dolgo, kot vam naroči zdravnik.
Consult your doctor if your symptoms return but do not stop taking Olanzapine Apotex unless your doctor tells you to. 
Če se simptomi povrnejo, se posvetujte s svojim zdravnikom, vendar ne prenehajte jemati zdravila Olanzapin Apotex, če vam tega ne naroči zdravnik.
• Tell the doctor if you or someone else in your family has a history of blood clots, as medicines like these have been associated with formation of blood clots. 
• Če ste vi ali kdo iz vaše družine v preteklosti imeli krvne strdke, morate o tem obvestiti zdravnika, saj lahko zdravila, kot je to, povzročijo nastanek krvnih strdkov.
Patients treated with any antipsychotic medicines, including Olanzapine Apotex, should be observed for signs and symptoms of hyperglycaemia (such as polydipsia, polyuria, polyphagia, and weakness) and patients with diabetes mellitus or with risk factors for diabetes mellitus should be monitored regularly for worsening of glucose control. 
Bolnike, zdravljene s katerimkoli antipsihotikom, vključno z zdravilom Olanzapin Apotex, moramo opazovati za znake in simptome hiperglikemije (kot so polidipsija, poliurija, polifagija in šibkost) ter redno spremljati bolnike s sladkorno boleznijo ali dejavniki tveganja za sladkorno bolezen glede poslabšanja nadzora glukoze.
• unusual movement (a common side effect that may affect up to 1 in 10 people) mainly of the face or tongue; 
• nenavadne zgibke (pogost neželeni učinek, ki lahko prizadene do 1 od 10 bolnikov), posebno v mišicah obraza ali jezika;
• Very rarely, medicines of this type cause a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness. 
• Zelo redko tovrstna zdravila povzročijo kombinacijo zvišanja telesne temperature, pospešenega dihanja, znojenja, okorelosti mišic in dremavosti ali zaspanosti.
• blood clots in the veins (an uncommon side effect that may affect up to 1 in 100 people) especially in the legs (symptoms include swelling, pain, and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing. 
• krvne strdke v venah (občasen neželeni učinek, ki lahko prizadene do 1 od 100 bolnikov), posebej v nogah (simptomi vključujejo otekanje, bolečino in rdečino na nogah), ki lahko po žilah potujejo v pljuča ter povzročijo bolečino v pljučih in težave z dihanjem.
• Stroke or “mini” stroke (temporary symptoms of stroke) 
• možgansko kap ali »majhno« možgansko kap (prehodni znaki kapi)
Repeated dose toxicity 
Toksičnost pri ponavljajočih se odmerkih
In one clinical trial in patients with bipolar mania, valproate combination therapy with olanzapine resulted in an incidence of neutropenia of 4.1%; a potential contributing factor could be high plasma valproate levels. 
V enem kliničnem preskušanju pri bolnikih z bipolarno manijo, je kombinirano zdravljenje z valproatom in olanzapinom povzročilo incidenco nevtropenije 4,1 %; možen vzročni dejavnik so lahko visoke plazemske ravni valproata.
If you take more Olanzapine Apotex than you should Patients who have taken more Olanzapine Apotex than they should have experienced the following symptoms: rapid beating of the heart, agitation/aggressiveness, problems with speech, unusual movements (especially of the face or tongue) and reduced level of consciousness. 
Če ste vzeli večji odmerek zdravila Olanzapin Apotex, kot bi smeli Bolniki, ki so vzeli večji odmerek zdravila Olanzapin Apotex, kot bi smeli, so imeli naslednje simptome: hitro bitje srca, vznemirjenost/agresivnost, težave pri govoru, nenavadne zgibke (posebno v mišicah obraza ali jezika) in zmanjšano stopnjo zavesti.
Manic episode: The starting dose is 15 mg as a single daily dose in monotherapy or 10 mg daily in combination therapy (see section 5.1). 
Manična epizoda: Začetni odmerek je 15 mg v enkratnem dnevnem odmerku pri monoterapiji ali 10 mg na dan pri kombiniranem zdravljenju (glejte poglavje 5.1).
Olanzapine administered with lithium or valproate resulted in increased levels (10%) of tremor, dry mouth, increased appetite, and weight gain. 
Olanzapin dan z litijem ali valproatom je povzročil zvišane ravni (≥ 10 %) tresenja, suhih ust, povečanega apetita in povečanja telesne mase.
Thromboembolism (including pulmonary embolism and deep vein thrombosis) (see section 4.4) 
Trombembolija (vključno s pljučno embolijo in globoko vensko trombozo) (glejte poglavje 4.4)
Estrous cycles were affected at doses of 1.1 mg/kg (3 times the maximum human dose) and reproduction parameters were influenced in rats given 3 mg/kg (9 times the maximum human dose). 
Odmerki 1,1 mg/kg (3-kratni maksimalni odmerek za človeka) so vplivali na estrus cikluse, odmerki 3 mg/kg (9-kratni maksimalni odmerek za človeka) pa so pri podganah vplivali na parametre reprodukcije.
You should take your Olanzapine Apotex tablets once a day following the advice of your doctor. 
Olanzapin Apotex tablete jemljite enkrat na dan, in sicer upoštevajte nasvet zdravnika.